Logo image of ACO-X.CA

ATCO LTD -CLASS I (ACO-X.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:ACO-X - CA0467894006 - Common Stock

57.5 CAD
+0.09 (+0.16%)
Last: 1/13/2026, 7:00:00 PM
Fundamental Rating

4

ACO-X gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 19 industry peers in the Multi-Utilities industry. ACO-X has an average financial health and profitability rating. ACO-X has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ACO-X was profitable.
  • ACO-X had a positive operating cash flow in the past year.
  • In the past 5 years ACO-X has always been profitable.
  • In the past 5 years ACO-X always reported a positive cash flow from operatings.
ACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

  • ACO-X's Return On Assets of 1.55% is in line compared to the rest of the industry. ACO-X outperforms 42.11% of its industry peers.
  • ACO-X's Return On Equity of 9.08% is amongst the best of the industry. ACO-X outperforms 89.47% of its industry peers.
  • ACO-X has a worse Return On Invested Capital (3.73%) than 73.68% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ACO-X is in line with the industry average of 3.73%.
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROIC 3.73%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ACO-X.CA Yearly ROA, ROE, ROICACO-X.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • ACO-X has a Profit Margin (8.38%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of ACO-X has declined.
  • Looking at the Operating Margin, with a value of 24.56%, ACO-X is in line with its industry, outperforming 42.11% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ACO-X has declined.
  • ACO-X has a Gross Margin (74.90%) which is comparable to the rest of the industry.
  • ACO-X's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
ACO-X.CA Yearly Profit, Operating, Gross MarginsACO-X.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACO-X is destroying value.
  • ACO-X has about the same amout of shares outstanding than it did 1 year ago.
  • ACO-X has less shares outstanding than it did 5 years ago.
  • ACO-X has a worse debt/assets ratio than last year.
ACO-X.CA Yearly Shares OutstandingACO-X.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ACO-X.CA Yearly Total Debt VS Total AssetsACO-X.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

  • Based on the Altman-Z score of 0.78, we must say that ACO-X is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ACO-X (0.78) is better than 84.21% of its industry peers.
  • ACO-X has a debt to FCF ratio of 27.90. This is a negative value and a sign of low solvency as ACO-X would need 27.90 years to pay back of all of its debts.
  • ACO-X has a Debt to FCF ratio of 27.90. This is amongst the best in the industry. ACO-X outperforms 100.00% of its industry peers.
  • A Debt/Equity ratio of 2.64 is on the high side and indicates that ACO-X has dependencies on debt financing.
  • ACO-X's Debt to Equity ratio of 2.64 is on the low side compared to the rest of the industry. ACO-X is outperformed by 73.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Altman-Z 0.78
ROIC/WACC0.73
WACC5.11%
ACO-X.CA Yearly LT Debt VS Equity VS FCFACO-X.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.81 indicates that ACO-X should not have too much problems paying its short term obligations.
  • ACO-X has a Current ratio of 1.81. This is amongst the best in the industry. ACO-X outperforms 100.00% of its industry peers.
  • ACO-X has a Quick Ratio of 1.66. This is a normal value and indicates that ACO-X is financially healthy and should not expect problems in meeting its short term obligations.
  • ACO-X's Quick ratio of 1.66 is amongst the best of the industry. ACO-X outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.66
ACO-X.CA Yearly Current Assets VS Current LiabilitesACO-X.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 10.19% over the past year.
  • Measured over the past 5 years, ACO-X shows a small growth in Earnings Per Share. The EPS has been growing by 6.10% on average per year.
  • The Revenue has been growing slightly by 7.75% in the past year.
  • The Revenue has been growing slightly by 0.98% on average over the past years.
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%

3.2 Future

  • Based on estimates for the next years, ACO-X will show a small growth in Earnings Per Share. The EPS will grow by 4.90% on average per year.
  • Based on estimates for the next years, ACO-X will show a small growth in Revenue. The Revenue will grow by 2.20% on average per year.
EPS Next Y8.92%
EPS Next 2Y4.96%
EPS Next 3Y4.9%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y1.49%
Revenue Next 3Y2.2%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ACO-X.CA Yearly Revenue VS EstimatesACO-X.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
ACO-X.CA Yearly EPS VS EstimatesACO-X.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.67 indicates a correct valuation of ACO-X.
  • Compared to the rest of the industry, the Price/Earnings ratio of ACO-X is on the same level as its industry peers.
  • ACO-X's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
  • With a Price/Forward Earnings ratio of 12.17, ACO-X is valued correctly.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ACO-X.
  • ACO-X is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.67
Fwd PE 12.17
ACO-X.CA Price Earnings VS Forward Price EarningsACO-X.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 78.95% of the companies in the same industry are more expensive than ACO-X, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ACO-X is valued a bit cheaper than the industry average as 63.16% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.89
EV/EBITDA 8.42
ACO-X.CA Per share dataACO-X.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • ACO-X's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.42
PEG (5Y)2.07
EPS Next 2Y4.96%
EPS Next 3Y4.9%

6

5. Dividend

5.1 Amount

  • ACO-X has a Yearly Dividend Yield of 3.55%.
  • Compared to an average industry Dividend Yield of 5.23, ACO-X's dividend is way lower than its industry peers. On top of this 94.74% of the companies listed in the same industry pay a better dividend than ACO-X!
  • Compared to an average S&P500 Dividend Yield of 1.92, ACO-X pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.55%

5.2 History

  • The dividend of ACO-X has a limited annual growth rate of 3.93%.
  • ACO-X has paid a dividend for at least 10 years, which is a reliable track record.
  • ACO-X has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.93%
Div Incr Years31
Div Non Decr Years34
ACO-X.CA Yearly Dividends per shareACO-X.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 52.20% of the earnings are spent on dividend by ACO-X. This is a bit on the high side, but may be sustainable.
  • The dividend of ACO-X is growing, but earnings are growing more, so the dividend growth is sustainable.
DP52.2%
EPS Next 2Y4.96%
EPS Next 3Y4.9%
ACO-X.CA Yearly Income VS Free CF VS DividendACO-X.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M
ACO-X.CA Dividend Payout.ACO-X.CA Dividend Payout, showing the Payout Ratio.ACO-X.CA Dividend Payout.PayoutRetained Earnings

ATCO LTD -CLASS I

TSX:ACO-X (1/13/2026, 7:00:00 PM)

57.5

+0.09 (+0.16%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07
Earnings (Next)02-25
Inst Owners27.8%
Inst Owner ChangeN/A
Ins Owners0.69%
Ins Owner ChangeN/A
Market Cap6.45B
Revenue(TTM)5.14B
Net Income(TTM)431.00M
Analysts78.67
Price Target61.49 (6.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.55%
Yearly Dividend1.96
Dividend Growth(5Y)3.93%
DP52.2%
Div Incr Years31
Div Non Decr Years34
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.14%
Min EPS beat(2)-3.78%
Max EPS beat(2)8.05%
EPS beat(4)3
Avg EPS beat(4)2.22%
Min EPS beat(4)-3.78%
Max EPS beat(4)8.05%
EPS beat(8)7
Avg EPS beat(8)4.37%
EPS beat(12)9
Avg EPS beat(12)2.66%
EPS beat(16)12
Avg EPS beat(16)4.06%
Revenue beat(2)0
Avg Revenue beat(2)-9.84%
Min Revenue beat(2)-17.7%
Max Revenue beat(2)-1.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.73%
Min Revenue beat(4)-18.52%
Max Revenue beat(4)-0.7%
Revenue beat(8)0
Avg Revenue beat(8)-11.91%
Revenue beat(12)0
Avg Revenue beat(12)-10.29%
Revenue beat(16)1
Avg Revenue beat(16)-9.26%
PT rev (1m)3.35%
PT rev (3m)7.65%
EPS NQ rev (1m)-0.47%
EPS NQ rev (3m)-0.2%
EPS NY rev (1m)-0.34%
EPS NY rev (3m)1.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)5.26%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE 12.67
Fwd PE 12.17
P/S 1.25
P/FCF 13.89
P/OCF 2.64
P/B 1.36
P/tB 1.91
EV/EBITDA 8.42
EPS(TTM)4.54
EY7.9%
EPS(NY)4.73
Fwd EY8.22%
FCF(TTM)4.14
FCFY7.2%
OCF(TTM)21.76
OCFY37.84%
SpS45.88
BVpS42.35
TBVpS30.16
PEG (NY)1.42
PEG (5Y)2.07
Graham Number65.77
Profitability
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROCE 4.79%
ROIC 3.73%
ROICexc 3.92%
ROICexgc 4.15%
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
FCFM 9.02%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ROICexc(3y)4.06%
ROICexc(5y)3.97%
ROICexgc(3y)4.27%
ROICexgc(5y)4.16%
ROCE(3y)5.04%
ROCE(5y)4.9%
ROICexgc growth 3Y1.58%
ROICexgc growth 5Y-6.25%
ROICexc growth 3Y1.11%
ROICexc growth 5Y-6.55%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Debt/EBITDA 5.96
Cap/Depr 234.56%
Cap/Sales 38.4%
Interest Coverage 2.33
Cash Conversion 115.87%
Profit Quality 107.66%
Current Ratio 1.81
Quick Ratio 1.66
Altman-Z 0.78
F-Score7
WACC5.11%
ROIC/WACC0.73
Cap/Depr(3y)212.07%
Cap/Depr(5y)195.52%
Cap/Sales(3y)33.77%
Cap/Sales(5y)31.75%
Profit Quality(3y)134.57%
Profit Quality(5y)187.54%
High Growth Momentum
Growth
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
EPS Next Y8.92%
EPS Next 2Y4.96%
EPS Next 3Y4.9%
EPS Next 5YN/A
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%
Revenue Next Year0%
Revenue Next 2Y1.49%
Revenue Next 3Y2.2%
Revenue Next 5YN/A
EBIT growth 1Y25.67%
EBIT growth 3Y7.57%
EBIT growth 5Y-2.22%
EBIT Next Year433.88%
EBIT Next 3Y81.02%
EBIT Next 5YN/A
FCF growth 1Y1.09%
FCF growth 3Y-8.79%
FCF growth 5Y2.94%
OCF growth 1Y16.42%
OCF growth 3Y5.63%
OCF growth 5Y7.34%

ATCO LTD -CLASS I / ACO-X.CA FAQ

What is the ChartMill fundamental rating of ATCO LTD -CLASS I (ACO-X.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ACO-X.CA.


What is the valuation status of ATCO LTD -CLASS I (ACO-X.CA) stock?

ChartMill assigns a valuation rating of 4 / 10 to ATCO LTD -CLASS I (ACO-X.CA). This can be considered as Fairly Valued.


What is the profitability of ACO-X stock?

ATCO LTD -CLASS I (ACO-X.CA) has a profitability rating of 4 / 10.


Can you provide the financial health for ACO-X stock?

The financial health rating of ATCO LTD -CLASS I (ACO-X.CA) is 5 / 10.


What is the expected EPS growth for ATCO LTD -CLASS I (ACO-X.CA) stock?

The Earnings per Share (EPS) of ATCO LTD -CLASS I (ACO-X.CA) is expected to grow by 8.92% in the next year.